Overexpression of long noncoding RNA ENST433110 inhibits cell proliferation and migration and enhances cell apoptosis of thyroid cancer cells

References

• 2016. SAMMSON long noncoding RNA Is essential for melanoma cell viability. Cancer Discov.
   Google Scholar
• Balcin O, Ak Aksoy S, Tunca B, Kaya E, Egeli U, Tezcan G, Ugras N, Cecener G, Isik O, Dundar HZ, Yerci O. 2018. Overexpression of the long noncoding RNA homeoboxa transcript at the distal tip predicts poor prognosis in a KRAS-independent manner in periampullary Region Tumors. Pancreas. 47(2):213–220. doi: https://doi.org/10.1097/MPA.0000000000000984
   Google Scholar
• Beltrami CM, Dos Reis MB, Barros-Filho MC, Marchi FA, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR. 2017. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas. Clin Epigenetics. 9:45. doi: https://doi.org/10.1186/s13148-017-0346-2
   PubMed Web of Science ®Google Scholar
• Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu DY, Tang CJ, De W, Yang F. 2018. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer. 17(1):6. doi: https://doi.org/10.1186/s12943-017-0756-y
   PubMed Web of Science ®Google Scholar
• Ding J, Wang F, Xiang T, Qiao M. 2018. Expression and function of long noncoding RNA NONHSAT129183 in papillary thyroid cancer. Oncol Res. 26(7):1047–1053. doi: https://doi.org/10.3727/096504018X15152037713570
   Google Scholar
• Giusti M, Mittica M, Comite P, Campana C, Gay S, Mussap M. 2018. Anti-mullerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer. Endocrine. 60(3):516–523. doi: https://doi.org/10.1007/s12020-017-1510-3
   Google Scholar
• Goding CR. 2016. Targeting the lncRNA SAMMSON reveals metabolic vulnerability in melanoma. Cancer Cell. 29(5):619–621. doi: https://doi.org/10.1016/j.ccell.2016.04.010
   Google Scholar
• Hao XS, Hao JH, Liu FT, Newland AC, Jia L. 2003. Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis. Apoptosis. 8(6):601–607. doi: https://doi.org/10.1023/A:1026131425204
   Google Scholar
• Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM, Ma XK, Zhu ZZ, Zhou R. 2017. LncRNA-MALAT1 promotes angiogenesis of thyroid cancer by modulating tumor-associated macrophage FGF2 protein secretion. J Cell Biochem. 118(12):4821–4830. doi: https://doi.org/10.1002/jcb.26153
   PubMed Web of Science ®Google Scholar
• Kwon H, Jeon MJ, Yoon JH, Hong SJ, Lee JH, Kim TY, Shong YK, Kim WB, Kim WG, Song DE. 2017. Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomas. J Surg Oncol. 116(6):746–755. doi: https://doi.org/10.1002/jso.24700
   Google Scholar
• Kwon MR, Shin JH, Hahn SY, Oh YL, Kwak JY, Lee E, Lim Y. 2018. Histogram analysis of greyscale sonograms to differentiate between the subtypes of follicular variant of papillary thyroid cancer. Clin Radiol. 73(6):591 e1-591 e7. doi: https://doi.org/10.1016/j.crad.2017.12.008
   Google Scholar
• Ladurner D, Seeber G, Hofstadter F. 1984. [Papillary thyroid cancer--prognosis and prognostic factors]. Langenbecks Arch Chir. 363(1):43–55. doi: https://doi.org/10.1007/BF01255776
   Google Scholar
• Li Q, Pan X, Wang X, Jiao X, Zheng J, Li Z, Huo Y. 2017. Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma. Oncotarget. 8(63):106648–106660. doi: https://doi.org/10.18632/oncotarget.20678
   PubMedGoogle Scholar
• Liao X, Chen J, Liu Y, He A, Wu J, Cheng J, Zhang X, Lv Z, Wang F, Mei H. 2018. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer. Cancer Biomark. 21(2):277–285. doi: https://doi.org/10.3233/CBM-170354
   PubMed Web of Science ®Google Scholar
• Liu N, Zhou Q, Qi YH, Wang H, Yang L, Fan QY. 2017. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis. Exp Mol Pathol. 103(1):71–77. doi: https://doi.org/10.1016/j.yexmp.2017.06.004
   Google Scholar
• Mehra R, Shi Y, Udager AM, Prensner JR, Sahu A, Iyer MK, Siddiqui J, Cao X, Wei J, Jiang H, et al. 2014. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia. 16(12):1121–1127. doi: https://doi.org/10.1016/j.neo.2014.11.006
   PubMed Web of Science ®Google Scholar
• Shi J, Wang YJ, Sun CR, Qin B, Zhang Y, Chen G. 2017. Long noncoding RNA lncHERG promotes cell proliferation, migration and invasion in glioblastoma. Oncotarget. 8(64):108031–108041. doi: https://doi.org/10.18632/oncotarget.22446
   Google Scholar
• Staunton MD, Skeet RG. 1979. Thyroid cancer: prognosis in 469 patients. Br J Surg. 66(9):643–647. doi: https://doi.org/10.1002/bjs.1800660915
   Google Scholar
• Stojanovic M, Stojanovic D, Rancic N, Ignjatovic A, Antic Z, Miljkovic S, Rajovic T. 2017. Trends in thyroid cancer incidence and mortality in Central Serbia, 1999-2014. Ann Ist Super Sanita. 53(4):299–304.
   Web of Science ®Google Scholar
• Takahashi H, Takahashi K, Shimura H, Yasumura S, Suzuki S, Ohtsuru A, Midorikawa S, Ohira T, Ohto H, Yamashita S, Kamiya K. 2017. Simulation of expected childhood and adolescent thyroid cancer cases in Japan using a cancer-progression model based on the national cancer registry: application to the first-round thyroid examination of the Fukushima Health Management Survey. Medicine (Baltimore). 96(48):e8631. doi: https://doi.org/10.1097/MD.0000000000008631
   Google Scholar
• Tavarelli M, Sarfati J, Chereau N, Tissier F, Golmard JL, Ghander C, Lussey-Lepoutre C, Trésallet C, Menegaux F, Leenhardt L, Buffet C. 2017. Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification. Thyroid. 27(6):778–786. doi: https://doi.org/10.1089/thy.2016.0512
   Google Scholar
• Wang CW, Lee YC, Calista E, Zhou F, Zhu H, Suzuki R, Komura D, Ishikawa S, Cheng SP. 2018. A benchmark for comparing precision medicine methods in thyroid cancer diagnosis using tissue microarrays. Bioinformatics. 34(10):1767–1773. doi: https://doi.org/10.1093/bioinformatics/btx838
   Google Scholar
• Wang P, Liu G, Xu W, Liu H, Bu Q, Sun D. 2017. Long noncoding RNA H19 inhibits cell viability, migration, and invasion via downregulation of IRS-1 in thyroid cancer cells. Technol Cancer Res Treat. 16(6):1102–1112. doi: https://doi.org/10.1177/1533034617733904
   Google Scholar
• Weeks KS, Kahl AR, Lynch CF, Charlton ME. 2018. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014. Cancer. 124(7):1483–1491. doi: https://doi.org/10.1002/cncr.31229
   Google Scholar
• Williard W, Borgen P, Bol R, Tiwari R, Osborne M. 1992. Cowden's disease. A case report with analyses at the molecular level. Cancer. 69(12):2969–2974. doi: https://doi.org/10.1002/1097-0142(19920615)69:12<2969::AID-CNCR2820691217>3.0.CO;2-2
   Google Scholar
• Xhaard C, Rubino C, Souchard V, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, et al. 2018. Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case-control study. Cancer Epidemiol. 52:142–147. doi: https://doi.org/10.1016/j.canep.2017.12.015
   Google Scholar
• Zhai X, Xu W. 2018. Long noncoding RNA ATB Promotes proliferation, migration, and invasion in bladder cancer by suppressing MicroRNA-126. Oncol Res. 26(7):1063–1072. doi: https://doi.org/10.3727/096504018X15152072098476
   Google Scholar
• Zhang H, Cai Y, Zheng L, Zhang Z, Lin X, Jiang N. 2018. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J Cell Physiol. 233(10):6638–6648. doi: https://doi.org/10.1002/jcp.26425
   PubMed Web of Science ®Google Scholar
• Zhou J, Xiao H, Yang X, Tian H, Xu Z, Zhong Y, Ma L, Zhang W, Qiao G, Liang J. 2018. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. Sci Rep. 8(1):37. doi: https://doi.org/10.1038/s41598-017-18280-3
   PubMedGoogle Scholar